Change - Announcement of Appointment::Appointment of Chief Executive Officer (Interim)

Issuer & Securities

Issuer/ Manager
NANOFILM TECHNOLOGIES INTERNATIONAL LIMITED
Securities
NANOFILM TECHNOLOGIES INTL LTD - SGXE61652363 - MZH
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
23-Jun-2021 01:29:46
Status
New
Announcement Sub Title
Appointment of Chief Executive Officer (Interim)
Announcement Reference
SG210623OTHRW9ZQ
Submitted By (Co./ Ind. Name)
Lim Kian Onn
Designation
Chief Financial Officer
Description (Please provide a detailed description of the event in the box below)
Appointment of Chief Executive Officer (Interim)

Credit Suisse (Singapore) Limited and Oversea-Chinese Banking Corporation Limited are the Joint Issue Managers for the initial public offering of shares in, and listing of, the Company on the Mainboard of the SGX-ST on 30 October 2020 ("Offering"). Citigroup Global Markets Singapore Pte. Ltd., Credit Suisse (Singapore) Limited and Oversea-Chinese Banking Corporation Limited are the Joint Global Coordinators for the Offering. Citigroup Global Markets Singapore Pte. Ltd., CLSA Singapore Pte Ltd, Credit Suisse (Singapore) Limited and Oversea-Chinese Banking Corporation Limited are the Joint Bookrunners and Underwriters for the Offering.

Additional Details

Date Of Appointment
22/06/2021
Name Of Person
Dr Shi Xu
Age
57
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
Following the resignation of Mr Lee Liang Huang as Chief Executive Officer (CEO) of Nanofilm Technologies International Limited (Company) due to health reasons, and taking into consideration that Mr Lee will have to take regular time off to attend to his health before the effective date of his resignation, and that time is needed to source for and/or identify a suitable candidate to take over the position of CEO, the Nominating Committee has reviewed and considered it appropriate to appoint an interim CEO to oversee the management of the operations of the Group until such time that a suitable replacement is appointed to assume the position of CEO. Dr Shi Xu, the Executive Chairman of the Company, was the CEO of the Group from 1999 to 2017, and he is most suited to take on this role having regard to his extensive experience and knowledge of the business of the Group. The Board considered and accepted the recommendation of the Nominating Committee to appoint Dr Shi as CEO (Interim) until such time that a replacement is appointed to take over the position of CEO.

Whether appointment is executive, and if so, the area of responsibility
Executive position. The primary areas of responsibility are to oversee the overall management of the operations and resources of the Group, including planning and implementing the strategic direction of the Group.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
CEO (Interim)
Professional qualifications
Bachelor of Science (Physics) - Tongji University
Doctor of Philosophy (Physics) - University of Reading
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
Spouse of Madam Jin Xiao Qun, a substantial shareholder of the Company
Conflict of interests (including any competing business)
None
Working experience and occupation(s) during the past 10 years
1999 to 2000 - CEO of the Company
2001 to 2017 - Executive Chairman and CEO of the Company
2018 to present - Executive Chairman of the Company
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Direct interest - 50,842,820 shares of Company
Deemed interest - 311,584,895 shares of Company
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
None
Present
Nanofilm Technologies International Limited
Nanofilm Advanced Materials Pte. Ltd.
Wizture Holdings Pte. Ltd.
Nanofab Technologies Pte. Ltd.
Nanofilm Vacuum Coating (Shanghai) Co., Ltd
Nanofilm Renewable Energy Technology (Shanghai) Co., Ltd
Nanofilm Enterprise Management (Shanghai) Co., Ltd
Yizheng Nahuan Technologies Co., Ltd
Nanofilm Technologies Japan Limited
Nanofab Japan Co., Ltd
Nanofab Vietnam Co., Ltd
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
Yes
If Yes, Please provide details of prior experience
NA
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
NA